{"transactions":[{"id":4614174,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"grant","planned":false,"acquired":true,"shares":161654,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter."}],"balance_after":161654,"derivative":{"exercise_price":6.375,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":161654},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614173,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"grant","planned":false,"acquired":true,"shares":96129,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter."}],"balance_after":96129,"derivative":{"exercise_price":6.375,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":96129},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614172,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"grant","planned":false,"acquired":true,"shares":173913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter."}],"balance_after":173913,"derivative":{"exercise_price":6.375,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":173913},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614171,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"grant","planned":false,"acquired":true,"shares":254751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027."}],"balance_after":254751,"derivative":{"exercise_price":6.375,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":254751},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614170,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean February 27, 2025."}],"balance_after":0,"derivative":{"exercise_price":28.21,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614169,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":149000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 4, 2024."}],"balance_after":0,"derivative":{"exercise_price":56.07,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":149000},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614168,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 9, 2023."}],"balance_after":0,"derivative":{"exercise_price":14.95,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":4614167,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-09-10T00:53:51.000Z","date":"2026-09-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":338819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share."}],"balance_after":0,"derivative":{"exercise_price":16,"exercise_date":"2025-07-30","expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":338819},"source":{"system":"sec-edgar","filing":"0001193125-26-386838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526386838/ownership.xml","form_type":"4"}},{"id":1565,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-03T01:35:37.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":false,"shares":13425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the \"Plan\")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the \"Plan\")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029."}],"balance_after":67120,"derivative":{"underlying":"Common Stock","underlying_shares":13425},"source":{"system":"sec-edgar","filing":"0001193125-26-380714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526380714/ownership.xml","form_type":"4"}},{"id":1564,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T01:35:37.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":5100,"price":6.96,"value":35496.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."}],"balance_after":71775,"source":{"system":"sec-edgar","filing":"0001193125-26-380714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526380714/ownership.xml","form_type":"4"}},{"id":1563,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T01:35:37.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":true,"shares":13425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":76875,"source":{"system":"sec-edgar","filing":"0001193125-26-380714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295469/000119312526380714/ownership.xml","form_type":"4"}},{"id":869607,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-03-04T01:19:30.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":80545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the \"Plan\")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the \"Plan\")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029."}],"balance_after":80545,"derivative":{"underlying":"Common Stock","underlying_shares":80545},"source":{"system":"sec-edgar","filing":"0001193125-26-089481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526089481/ownership.xml","form_type":"4"}},{"id":1241393,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T01:03:32.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean February 27, 2025."}],"balance_after":215000,"derivative":{"exercise_price":28.21,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-25-029394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025029394/ownership.xml","form_type":"4"}},{"id":1437165,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-09T21:57:16.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":false,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the \"2015 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean February 24, 2017. The option originally covered 570,000 shares of common stock pre 10.33 for 1 reverse split shares."}],"balance_after":0,"derivative":{"exercise_price":4.3386,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0000950170-24-094918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024094918/ownership.xml","form_type":"4"}},{"id":1437164,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-09T21:57:16.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":false,"shares":7650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the \"2015 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 23, 2020. The option originally covered 500,000 shares of common stock pre 10.33 for 1 reverse split shares."}],"balance_after":19186,"derivative":{"exercise_price":15.0818,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0000950170-24-094918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024094918/ownership.xml","form_type":"4"}},{"id":1437163,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-08-09T21:57:16.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":true,"shares":2300,"price":4.3386,"value":9978.78,"ownership":{"direct":true},"balance_after":63450,"source":{"system":"sec-edgar","filing":"0000950170-24-094918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024094918/ownership.xml","form_type":"4"}},{"id":1437162,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-08-09T21:57:16.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":true,"shares":7650,"price":15.0818,"value":115375.77,"ownership":{"direct":true},"balance_after":61150,"source":{"system":"sec-edgar","filing":"0000950170-24-094918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024094918/ownership.xml","form_type":"4"}},{"id":1455494,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-12T23:12:01.000Z","date":"2024-07-11","kind":"exercise","planned":false,"acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the \"2015 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 23, 2020. The option originally covered 500,000 shares of common stock pre 10.33 for 1 reverse split shares."}],"balance_after":26836,"derivative":{"exercise_price":15.0818,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000950170-24-083334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024083334/ownership.xml","form_type":"4"}},{"id":1455493,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-12T23:12:01.000Z","date":"2024-07-11","kind":"exercise","planned":false,"acquired":true,"shares":13500,"price":15.0818,"value":203604.3,"ownership":{"direct":true},"balance_after":53500,"source":{"system":"sec-edgar","filing":"0000950170-24-083334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024083334/ownership.xml","form_type":"4"}},{"id":1526525,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-06T21:02:30.000Z","date":"2024-05-03","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":60.1468,"value":2405872.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $60.00 to $60.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":764610,"source":{"system":"sec-edgar","filing":"0000950170-24-053667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024053667/ownership.xml","form_type":"4"}},{"id":1592319,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T21:24:30.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":149000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 4, 2024."}],"balance_after":149000,"derivative":{"exercise_price":56.07,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":149000},"source":{"system":"sec-edgar","filing":"0000950170-24-027180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024027180/ownership.xml","form_type":"4"}},{"id":1683048,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-09T21:08:12.000Z","date":"2024-01-08","kind":"sale","planned":true,"acquired":false,"shares":31250,"price":45.0002,"value":1406256.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 31,250 shares sold in the price range of $45.00 to $45.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":804610,"source":{"system":"sec-edgar","filing":"0000950170-24-003332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024003332/ownership.xml","form_type":"4"}},{"id":1683047,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-09T21:08:12.000Z","date":"2024-01-08","kind":"sale","planned":true,"acquired":false,"shares":31250,"price":43.5,"value":1359375.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":835860,"source":{"system":"sec-edgar","filing":"0000950170-24-003332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024003332/ownership.xml","form_type":"4"}},{"id":1698138,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-29T21:57:40.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":22500,"price":41.0888,"value":924498.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 22,500 shares sold in the price range of $41.00 to $41.2875 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":867110,"source":{"system":"sec-edgar","filing":"0001209191-23-060012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123060012/doc4.xml","form_type":"4"}},{"id":1707783,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-19T00:07:14.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":39.4011,"value":788022.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.08 to $39.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":889610,"source":{"system":"sec-edgar","filing":"0001209191-23-059039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123059039/doc4.xml","form_type":"4"}},{"id":1707782,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-19T00:07:14.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":40.0082,"value":800164.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.5268 to $40.405 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":909610,"source":{"system":"sec-edgar","filing":"0001209191-23-059039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123059039/doc4.xml","form_type":"4"}},{"id":1959195,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-10T21:10:23.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 9, 2023."}],"balance_after":200000,"derivative":{"exercise_price":14.95,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-017794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123017794/doc4.xml","form_type":"4"}},{"id":2020363,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-13T23:19:14.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":40000,"price":12.5,"value":500000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-23-008846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123008846/doc4.xml","form_type":"4"}},{"id":2613322,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-05T23:27:47.000Z","date":"2021-08-05","kind":"purchase","acquired":true,"shares":3638,"price":13.8478,"value":50378.2964,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 3,638 shares purchased in the price range of $13.50 to $14.00 by Cricklewood LP. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Cricklewood LP.  The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse."}],"balance_after":804610,"source":{"system":"sec-edgar","filing":"0000899243-21-031814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031814/doc4.xml","form_type":"4"}},{"id":2613321,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-05T23:27:47.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":125000,"price":16,"value":2000000.0,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0000899243-21-031814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031814/doc4.xml","form_type":"4"}},{"id":2620301,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":1230,"kind":"person","name":"Kurtz Ronald M MD","position":1,"cik":"0001295469","reported_name":"Kurtz Ronald M MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2021-08-03T00:32:17.000Z","date":"2021-07-31","kind":"grant","acquired":true,"shares":338819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month).  \"Vesting Commencement Date\" shall mean July 30, 2021."}],"balance_after":338819,"derivative":{"exercise_price":16,"expiration_date":"2031-07-31","underlying":"Common Stock","underlying_shares":338819},"source":{"system":"sec-edgar","filing":"0000899243-21-031116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031116/doc4.xml","form_type":"4"}}]}